Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Anthera Pharmaceuticals Company Profile (NASDAQ:ANTH)

Consensus Ratings for Anthera Pharmaceuticals (NASDAQ:ANTH) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $7.80 (62.50% upside)

Analysts' Ratings History for Anthera Pharmaceuticals (NASDAQ:ANTH)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/30/2015Piper JaffrayBoost Price Target$7.50ViewTweet This Rating  Share This Rating on StockTwits
3/17/2015Jefferies GroupReiterated RatingBuy$18.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
2/12/2015ZacksDowngradeOutperform -> Neutral$3.90ViewTweet This Rating  Share This Rating on StockTwits
1/14/2015ZacksUpgradeNeutral -> Outperform$2.70ViewTweet This Rating  Share This Rating on StockTwits
9/30/2014ZacksDowngradeOutperform -> Neutral$2.10ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/27/2013 forward)